The Japanese Biochemical Society

1:30 PM - 2:45 PM

[1P-007] Combination with EGFR-TKI and Trametinib, a MEK inhibitor, overcomes resistance to EGFR-TKI in NSCLC

Kenji Takeuchi1, Mai Doyama1, Nao Kobayashi1, Fumiaki Ito2 (1.Fac. Pharm. Sci., Setsunan Univ., 2.Inst. Health Sci., Sunstar Inc.)

EGFR, 非小細胞肺がん, Trametinib, JNK, Bim

takeuchi@pharm.setsunan.ac.jp

Contents of this site has moved to the member page of The Japanese Biochemical Society: https://member.jbsoc.or.jp/mypage/
You can access the abstracts without credentials by accessing them via the member page.

You need the membership number and password to access the member page. Please contact the journal office for any inquiries.

Journal Office Contact Information:
E-mail:jbs-ho@jbsoc.or.jp
Tel:03(3815)1913 Fax:03(3815)1934

Password